本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.41
-0.6750-5.59%
成交量:17.38萬
成交額:198.52萬
市值:3.91億
市盈率:-12.21
高:12.12
開:12.11
低:11.08
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,425.49萬
流通股本:1,792.50萬
量比:2.25
換手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
淨資產收益率:-29.58%
總資產收益率:-19.93%
市淨率:2.13
市盈率(LYR):-10.89

資料載入中...

2019/08/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/10/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/09/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/09/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/07/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]